1-15 of 15
M Klein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin's Lymphoma Treated with Autologous Stem Cell Transplantation

Sabree Abedrabo, Tulio E. Rodriguez, Leonard M. Klein, Jacob Bitran
Journal: Blood
Blood (2023) 142 (Supplement 1): 7078.
https://doi.org/10.1182/blood-2023-174684
Published: 2023
Journal Articles

Risk Factors for the Development of Cardiac Arrhythmias during Hematopoietic Stem Cell Transplantation

Christopher Kapolas, PharmD, Jane Kosirog-Glowacki, PharmD, Kathryn L Barney, NP, Linda Advincula, NP, Leonard M. Klein, MD, Jacob D. Bitran, MD, Shams Bufalino, Tulio E Rodriguez, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3387.
https://doi.org/10.1182/blood-2018-99-120189
Published: 2018
Journal Articles

Avadomide (CC-122), a Novel Cereblon Modulating Agent, Plus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma

Loretta J. Nastoupil, MD, Fontanet Bijou, MD, Vincent Ribrag, MD, Julio C. Chavez, MD, Thomas E. Witzig, MD, David J. Andorsky, MD, Leonard M. Klein, MD, Daniel Greenwald, MD, Armando Santoro, MD, Paolo Corradini, MD, Ian W. Flinn, MD PhD, Randeep Sangha, MD, Vaishalee P. Kenkre, MD, Shailaja Uttamsingh, PhD, Patrick R. Hagner, PhD, Anita K. Gandhi, PhD, Tianlei Chen, PhD, Kristen Hege, MD, Michael Pourdehnad, MD, John Kuruvilla, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1602.
https://doi.org/10.1182/blood-2018-99-114409
Published: 2018
Journal Articles

Results of an Ongoing Phase 2 Study of Brentuximab Vedotin with Rchp As Frontline Therapy in Patients with High-Intermediate/High-Risk Diffuse Large B Cell Lymphoma (DLBCL)

Lihua E. Budde, MD PhD, Ahmad Halwani, Christopher A. Yasenchak, Charles Michael Farber, MD PhD, John M Burke, MD, Luis E. Fayad, MD, Beata Holkova, MD, Mark Knapp, MD, Kathryn S. Kolibaba, MD, Ranjana H Advani, MD, Stephen M Ansell, MD, PhD, Dipti Patel-Donnelly, MD, Habte A. Yimer, MD, Scott E. Smith, MD PhD, Moshe Yair Levy, MD, Mahesh Seetharam, MD, David Belada, MD PhD, Donald Brooks, MD, Edwin C. Kingsley, MD, Leonard M. Klein, Nina Wagner-Johnston, MD, Katherine Ruffner, Nancy L Bartlett, MD
Journal: Blood
Blood (2016) 128 (22): 104.
https://doi.org/10.1182/blood.V128.22.104.104
Published: 2016
Journal Articles

Results of a Phase 2 Trial Evaluating Efficacy and Safety of Entospletinib (GS-9973) in Patients with Mantle Cell Lymphoma

Jeffrey P. Sharman, Kathryn S. Kolibaba, Andrei R. Shustov, Thomas A. Giever, Leonard M. Klein, Derek Nay, Thomas A. Rado, Alfred Saleh, Danjie Zhang, Wen Shi, Andres Forero, Sarit Assouline
Journal: Blood
Blood (2016) 128 (22): 2963.
https://doi.org/10.1182/blood.V128.22.2963.2963
Published: 2016
Journal Articles

Phase 2 Trial of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Jeff P. Sharman, MD, Leonard M. Klein, MD, Michael Boxer, MD, Kathryn S. Kolibaba, MD, Steve Abella, MD, Julie Di Paolo, PhD, Clarence Eng, MPH, Jing Hu, PhD, Jing He, Anita Reddy, PhD, Christopher A. Yasenchak, MD
Journal: Blood
Blood (2015) 126 (23): 4152.
https://doi.org/10.1182/blood.V126.23.4152.4152
Published: 2015
Journal Articles

Phase 2 Trial of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Indolent Non-Hodgkin's Lymphoma (iNHL)

Jeff P. Sharman, MD, Leonard M. Klein, MD, Michael Boxer, MD, Kathryn S. Kolibaba, MD, Steve Abella, MD, Clarence Eng, MPH, Jing He, Jing Hu, PhD, Christopher A. Yasenchak, MD
Journal: Blood
Blood (2015) 126 (23): 1545.
https://doi.org/10.1182/blood.V126.23.1545.1545
Published: 2015
Journal Articles

a Phase 1/2 Trial of Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

James Berenson, MD, Laura Stampleman, MD, Alberto Bessudo, MD, Peter J Rosen, MD, Leonard M. Klein, MD, Thomas Woliver, MD, Marshall S. Flam, MD, Shahrooz Eshaghian, MD, Youram Nassir, MD, Swift A Regina, RN, Wang James, Eades Benjamin, PharmD, Tanya M. Spektor, PhD, Robert Vescio, MD
Journal: Blood
Blood (2015) 126 (23): 5383.
https://doi.org/10.1182/blood.V126.23.5383.5383
Published: 2015
Journal Articles

Single Donor Versus Acrodose Platelets in Oncology Patients: A Single Institutional Experience

Neil Dalal, DO, Naveed Cheema, D.O., Leonard M. Klein, MD
Journal: Blood
Blood (2014) 124 (21): 4298.
https://doi.org/10.1182/blood.V124.21.4298.4298
Published: 2014
Journal Articles

Phase 2 Trial of Entospletinib (GS-9973), a Selective SYK Inhibitor, in Follicular Lymphoma (FL)

Jeff P. Sharman, MD, Leonard M. Klein, MD, Michael Boxer, MD, Kathryn S. Kolibaba, MD, Michael J. Hawkins, MD, Steve Abella, MD, Meihua Wu, PhD, Christopher A. Yasenchak, MD
Journal: Blood
Blood (2014) 124 (21): 4419.
https://doi.org/10.1182/blood.V124.21.4419.4419
Published: 2014
Journal Articles

Ublituximab (TG-1101), a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Combination with Ibrutinib Is Highly Active in Patients with Relapsed and/or Refractory CLL and MCL; Results of a Phase II Trial

Jeff P. Sharman, MD, Charles M. Farber, MD PhD, Daruka Mahadevan, MD PhD, Marshall T. Schreeder, MD, Heather D. Brooks, MD, Kathryn S. Kolibaba, MD, Suzanne R. Fanning, DO, Leonard M. Klein, MD, Peter Sportelli, Hari P. Miskin, MS, Michael S. Weiss, Daniel R. Greenwald, MD
Journal: Blood
Blood (2014) 124 (21): 4679.
https://doi.org/10.1182/blood.V124.21.4679.4679
Published: 2014
Journal Articles

A Phase 1/2 Trial of Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Patients with Relapsed/Refractory Multiple Myeloma

James R. Berenson, MD, Laura V. Stampleman, MD, Alberto Bessudo, MD, Peter J. Rosen, MD, Leonard M Klein, MD, Thomas Woliver, MD, Marshall S. Flam, MD, Shahrooz Eshaghian, MD, Youram Nassir, MD, Regina A. Swift, RN, Robert Vescio, MD
Journal: Blood
Blood (2014) 124 (21): 4774.
https://doi.org/10.1182/blood.V124.21.4774.4774
Published: 2014
Journal Articles

A Phase 1/2 Study of Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Patients with Relapsed/Refractory Multiple Myeloma.

James R. Berenson, MD, James D. Hilger, Ph.D., Leonard M. Klein, MD, Shahrooz Eshaghian, MD, Youram Nassir, MD, Regina A. Swift, RN, Robert Vescio, MD
Journal: Blood
Blood (2012) 120 (21): 2979.
https://doi.org/10.1182/blood.V120.21.2979.2979
Published: 2012
Journal Articles

Indication of an involvement of interleukin-1 beta converting enzyme- like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes

SD Mundle, P Venugopal, JD Cartlidge, DV Pandav, L Broady-Robinson, S Gezer, EL Robin, SR Rifkin, M Klein, DE Alston, BM Hernandez, D Rosi, S Alvi, VT Shetty, SA Gregory, A Raza
Journal: Blood
Blood (1996) 88 (7): 2640–2647.
https://doi.org/10.1182/blood.V88.7.2640.bloodjournal8872640
Published: 1996
Journal Articles

THE EFFECT OF ADMINISTRATION OF EPINEPHRINE ON THE LEUKOCYTE COUNTS OF NORMAL SUBJECTS

COLIN WHITE, M.Sc., M.B., B. SURG., TSUIN HWA LING, M.D., ARNOLD M. KLEIN, A.B.
Journal: Blood
Blood (1950) 5 (8): 723–731.
https://doi.org/10.1182/blood.V5.8.723.723
Published: 1950